medigraphic.com
Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán

2023, Número 2

<< Anterior Siguiente >>

Rev Biomed 2023; 34 (2)


Síndrome de Gilles de la Tourette: revisión descriptiva

Bermont-Herrera EV, Juárez-Martínez J, Rosaldo-Rodríguez AA, Méndez-Domínguez N

Idioma: Español
Referencias bibliográficas: 44
Paginas: 235-244
Archivo PDF: 116.58 Kb.


RESUMEN

En 1885 Gilles de la Tourette describió por primera vez el síndrome de la Tourette que identificó en tres pacientes cuya conducta resultaba atípica dadas las manifestaciones motoras inusuales que exhibían como parte de su padecimiento. En tiempos de la postpandemia y aun ante los vertiginosos avances de la ciencia médica, es importante revisar los fundamentos para la sospecha clínica de síndrome de la Tourette, más aún ante la viralización de sus manifestaciones mediante las redes sociales. Nos planteamos como objetivo revisar las manifestaciones clínicas sugestivas del síndrome de la Tourette y su diferenciación diagnóstica. Se llevó a cabo una revisión descriptiva basada en los motores de búsqueda PubMed, Ebsco y Google Scholar. El síndrome de la Tourette es un trastorno del neurodesarrollo que se caracteriza por manifestarse en población joven, ciertos aspectos que se consideran desencadenantes y conductas que lo identifican pueden manifestarse de manera aislada, por lo que su tratamiento depende de un correcto y oportuno discernimiento diagnóstico. En resumen, el síndrome de la Tourette incluye signos y síntomas que parecieran hacerse más comunes ante la imitación de conductas normalizadas en las redes sociales, pero se diferencian del síndrome por su aparición aislada y refractaria.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Olvera C, Stebbins GT, Goetz CG, Kompoliti K. TikTokTics: A Pandemic Within a Pandemic. Mov DisordClin Pract. 2021 Aug 9;8(8):1200-05. doi: 10.1002/mdc3.13316.

  2. Hull M, Parnes M. Tics and TikTok: Functional TicsSpread Through Social Media. Mov Disord Clin Pract.2021 Jul 1;8(8):1248-52. doi: 10.1002/mdc3.13267.

  3. Elran-Barak R, Mozeikov M. One Month into theReinforcement of Social Distancing due to theCOVID-19 Outbreak: Subjective Health, HealthBehaviors, and Loneliness among People with ChronicMedical Conditions. Int J Environ Res Public Health.2020 Jul 27;17(15):5403. doi: 10.3390/ijerph17155403.

  4. Forsyth RJ. Tics, TikTok and COVID-19. Arch DisChild. 2021 Mar 12: archdischild-2021-321885. doi:10.1136/archdischild-2021-321885.

  5. Asociación Americana de Psiquiatría. ManualDiagnóstico y Estadístico de los Trastornos MentalesDSM-5. 5th Ed. Arlington: Editorial MédicaPanamericana; 2014.

  6. Velarde M, Cárdenas A. Trastornos del espectro autistay trastornos por déficit de atención con hiperactividad:desafíos en el diagnóstico y tratamiento [Autismspectrum disorder and attention-deficit/hyperactivitydisorder: challenge in diagnosis and treatment]. Medicina(B Aires). 2022 Aug 30;82 Suppl 3:67-70. Spanish.

  7. Jones KS, Saylam E, Ramphul K. Tourette SyndromeAnd Other Tic Disorders. 2022 Jun 14. In: StatPearls.Treasure Island (FL): StatPearls Publishing; 2022 Jan.

  8. Kleimaker A, Kleimaker M, Bäumer T, Beste C,Münchau A. Gilles de la Tourette Syndrome-A Disorderof Action-Perception Integration. Front Neurol. 2020Nov 26;11:597898. doi: 10.3389/fneur.2020.597898.

  9. Teive HAG, Germiniani FMB, Munhoz RP, Walusinski O.Charcot’s famous secretaries. Arq Neuropsiquiatr. 2017May;75(5):320-23. doi: 10.1590/0004-282X20170034.

  10. Rayego J, Suárez F. Corea. Med Fam SEMERGEN.2008;34(6):308-10. Doi 10.1016/S1138-3593(08)71909-9

  11. Carter KC. Germ theory, hysteria, and Freud’s earlywork in psychopathology. Med Hist. 1980 Jul;24(3):259-74. doi: 10.1017/s002572730004031x.

  12. Ueda K, Black KJ. Recent progress on Tourette syndrome.Fac Rev. 2021 Sep 7; 10:70. doi: 10.12703/r/10-70.

  13. Szejko N, Müller-Vahl KR. Challenges in the Diagnosisand Assessment in Patients with Tourette Syndromeand Comorbid Obsessive-Compulsive Disorder.Neuropsychiatr Dis Treat. 2021 Apr 30; 17:1253-66. doi:10.2147/NDT.S251499

  14. Valdés KM, Ayodeji UO. Síndrome de Gilles de la Tourette.Revista Cubana de Medicina General Integral. 2018;34(1):64-5. http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252018000100008&lng=es..

  15. Frey J, Malaty IA. Tourette Syndrome TreatmentUpdates: a Review and Discussion of the Current andUpcoming Literature. Curr Neurol Neurosci Rep. 2022Feb;22(2):123-42. doi: 10.1007/s11910-022-01177-8.

  16. Seideman MF, Seideman TA. A Review of the CurrentTreatment of Tourette Syndrome. J Pediatr PharmacolTher. 2020;25(5):401-12. doi: 10.5863/1551-6776-25.5.401.

  17. Rose O, Hartmann A, Worbe Y, Scharf JM, BlackKJ. Tourette syndrome research highlights from2018. F1000Res. 2019 Jul 1;8:988. doi: 10.12688/f1000research.19542.1.

  18. Liu ZS, Cui YH, Sun D, Lu Q, Jiang YW, JiangL, et al. Current Status, Diagnosis, and TreatmentRecommendation for Tic Disorders in China. FrontPsychiatry. 2020 Aug 13; 11:774. doi: 10.3389/fpsyt.2020.00774.

  19. Martino D, Pringsheim TM, Cavanna AE, Colosimo C,Hartmann A, Leckman JF, et al. Members of the MDSCommittee on Rating Scales Development. Systematicreview of severity scales and screening instruments fortics: Critique and recommendations. Mov Disord. 2017Mar;32(3):467-73. doi: 10.1002/mds.26891.

  20. Forcadell E, Garcia-Delgar B, Nicolau R, Pérez-VigilA, Cordovilla C, Lázaro L, et al. Tic disorders andpremonitory urges: validation of the Spanish-languageversion of the Premonitory Urge for Tics Scale inchildren and adolescents. Neurologia. 2022 Jul 9:S2173-5808(22)00071-2. doi: 10.1016/j.nrleng.2020.09.005.

  21. Openneer TJC, Tárnok Z, Bognar E, Benaroya-MilshteinN, Garcia-Delgar B, Morer A, et al. The PremonitoryUrge for Tics Scale in a large sample of children andadolescents: psychometric properties in a developmentalcontext. An EMTICS study. Eur Child AdolescPsychiatry. 2020 Oct;29(10):1411-24. doi: 10.1007/s00787-019-01450-1.

  22. Cox JH, Seri S, Cavanna AE. Sensory aspects of Tourettesyndrome. Neurosci Biobehav Rev. 2018 May; 88:170-76. doi: 10.1016/j.neubiorev.2018.03.016.

  23. Cavanna AE, Black KJ, Hallett M, Voon V. Neurobiologyof the Premonitory Urge in Tourette’s Syndrome:Pathophysiology and Treatment Implications. JNeuropsychiatry Clin Neurosci. 2017 Spring;29(2):95-04.doi: 10.1176/appi.neuropsych.16070141.

  24. Xu W, Zhang C, Deeb W, Patel B, Wu Y, Voon V, et al.Deep brain stimulation for Tourette’s syndrome. TranslNeurodegener. 2020 Jan 13;9:4. doi: 10.1186/s40035-020-0183-7.

  25. Levine JLS, Szejko N, Bloch MH. Meta-analysis:Adulthood prevalence of Tourette syndrome. ProgNeuropsychopharmacol Biol Psychiatry. 2019 Dec20;95:109675. doi: 10.1016/j.pnpbp.2019.109675.

  26. Haas M, Jakubovski E, Fremer C, Dietrich A, HoekstraPJ, Jäger B, et al. Yale Global Tic Severity Scale(YGTSS): Psychometric Quality of the Gold Standardfor Tic Assessment Based on the Large-Scale EMTICSStudy. Front Psychiatry. 2021 Feb 25;12:626459. doi:10.3389/fpsyt.2021.626459.

  27. Johnson KA, Worbe Y, Foote KD, Butson CR, GunduzA, Okun MS. Tourette syndrome: clinical features,pathophysiology, and treatment. Lancet Neurol. 2023Feb;22(2):147-158. doi: 10.1016/S1474-4422(22)00303-9.

  28. Lebowitz ER, Motlagh MG, Katsovich L, King RA,Lombroso PJ, Grantz H, et al. Tourette Syndrome StudyGroup, Kurlan RM, Leckman JF. Tourette syndrome inyouth with and without obsessive compulsive disorderand attention deficit hyperactivity disorder. Eur ChildAdolesc Psychiatry. 2012 Aug;21(8):451-57. doi:10.1007/s00787-012-0278-5. 2012 Apr 28.

  29. Stern JS. Tourette’s syndrome and its borderland.Pract Neurol. 2018 Aug;18(4):262-70. doi: 10.1136/practneurol-2017-001755.

  30. Szejko N, Saramak K, Lombroso A, Müller-Vahl K.Cannabis-based medicine in treatment of patients withGilles de la Tourette syndrome. Neurol Neurochir Pol.2022;56(1):28-38. doi: 10.5603/PJNNS.a2021.0081.

  31. Billnitzer A, Jankovic J. Current Management of Ticsand Tourette Syndrome: Behavioral, Pharmacologic,and Surgical Treatments. Neurotherapeutics. 2020Oct;17(4):1681-93. doi: 10.1007/s13311-020-00914-6.

  32. Pringsheim T, Okun MS, Müller-Vahl K, MartinoD, Jankovic J, Cavanna AE, et al. Practice guidelinerecommendations summary: Treatment of tics in peoplewith Tourette syndrome and chronic tic disorders.Neurology. 2019 May 7;92(19):896-06. doi: 10.1212/WNL.0000000000007466.

  33. García López MM. Tratamientos antipsicóticos en niñosy adolescentes: una revisión bibliográfica [Antipsychotictreatment in childhood and adolescence: a bibliographicalreview]. Actas Esp Psiquiatr. 2001 Jan-Feb;29(1):41-6.

  34. Pandey S, Srivanitchapoom P, Kirubakaran R, BermanBD. Botulinum toxin for motor and phonic tics inTourette’s syndrome. Cochrane Database Syst Rev.2018 Jan 5;1(1):CD012285. doi: 10.1002/14651858.CD012285.

  35. Levine A, Clemenza K, Rynn M, Lieberman J. Evidencefor the Risks and Consequences of Adolescent CannabisExposure. J Am Acad Child Adolesc Psychiatry. 2017Mar;56(3):214-25. doi: 10.1016/j.jaac.2016.12.014.

  36. Navarrete F, García-Gutiérrez MS, Gasparyan A,Austrich-Olivares A, Femenía T, Manzanares J. CannabisUse in Pregnant and Breastfeeding Women: Behavioraland Neurobiological Consequences. Front Psychiatry.2020 Nov 2;11:586447. doi: 10.3389/fpsyt.2020.586447.

  37. Nussey C, Pistrang N, Murphy T. How doespsychoeducation help? A review of the effects ofproviding information about Tourette syndrome andattention-deficit/hyperactivity disorder. Child CareHealth Dev. 2013 Sep;39(5):617-27. doi: 10.1111/cch.12039.

  38. Soós MJ, Coulson NS, Davies EB. Exploring SocialSupport in an Online Support Community for TouretteSyndrome and Tic Disorders: Analysis of Postings.J Med Internet Res. 2022 Oct 4;24(10):e34403. doi:10.2196/34403.

  39. Chadehumbe MA, Brown LW. Advances in the Treatmentof Tourette’s Disorder. Curr Psychiatry Rep. 2019 Mar18;21(5):31. doi: 10.1007/s11920-019-1018-z.

  40. Chen CW, Wang HS, Chang HJ, Hsueh CW. Effectivenessof a modified comprehensive behavioral interventionfor tics for children and adolescents with tourette’ssyndrome: A randomized controlled trial. J Adv Nurs.2020 Mar;76(3):903-15. doi: 10.1111/jan.14279.

  41. Bennett SM, Capriotti M, Bauer C, Chang S, KellerAE, Walkup J, et al. Development and Open Trial ofa Psychosocial Intervention for Young Children WithChronic Tics: The CBIT-JR Study. Behav Ther. 2020Jul;51(4):659-69. doi: 10.1016/j.beth.2019.10.004.

  42. Petruo V, Bodmer B, Bluschke A, Münchau A, RoessnerV, Beste C. Comprehensive Behavioral Intervention forTics reduces perception-action binding during inhibitorycontrol in Gilles de la Tourette syndrome. Sci Rep. 2020Jan 24;10(1):1174. doi: 10.1038/s41598-020-58269-z.

  43. McGuire JF, Ricketts EJ, Scahill L, Wilhelm S, WoodsDW, Piacentini J, et al. Effect of behavior therapyfor Tourette’s disorder on psychiatric symptomsand functioning in adults. Psychol Med. 2020Sep;50(12):2046-56. doi: 10.1017/S0033291719002150.

  44. Jankovic J. Treatment of tics associated withTourette syndrome. J Neural Transm (Vienna). 2020May;127(5):843-50. doi: 10.1007/s00702-019-02105-w.




2020     |     www.medigraphic.com